Final Version THROMBUS DEVELOPMENT AGREEMENTThrombus Development Agreement • July 28th, 2003 • Epix Medical Inc • In vitro & in vivo diagnostic substances • New York
THIS THROMBUS DEVELOPMENT AGREEMENT dated as of May 26, 2003 (the “Agreement”) is made by and between EPIX Medical, Inc., a Delaware corporation having its principal place of business at 71 Rogers Street, Cambridge, Massachusetts 02142-1118 USA (“EPIX”), and Schering Aktiengesellschaft, a German corporation having its principal place of business at 13342, Berlin, Germany (“Schering”).
